Two doses of daclizumab are sufficient for prolonged interleukin-2Ralpha chain blockade.
ter Meulen
C G
CG
Baan
C C
CC
Hené
R J
RJ
Hilbrands
L B
LB
Hoitsma
A J
AJ
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000077561:Daclizumab; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage*; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016030:Kidney Transplantation; D015375:Receptors, Interleukin-2 / Q000032:analysis / Q000037:antagonists & inhibitors*; D013997:Time Factors
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2; D000077561:Daclizumab